Market Place
Sourcing Support
AJOVY Reduces Episodic Migraine Days in SPACE Trial
14 Jan 2026 //
GLOBENEWSWIRE
Teva Showcases Growth Strategy At J.P. Morgan Healthcare Conf
11 Jan 2026 //
GLOBENEWSWIRE
Teva, Royalty Pharma Partner To Fast-Track Vitiligo Treatment
11 Jan 2026 //
GLOBENEWSWIRE
Teva To Present At 44Th J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
S&P Upgrades Teva to BB+; Moody`s Outlook Positive
24 Dec 2025 //
GLOBENEWSWIRE
Alvotech, Teva Set U.S. Date For AVT06, Biosimilar To Eylea
19 Dec 2025 //
GLOBENEWSWIRE
Teva’ Generics Dapagliflozin Receives Tentative Approval in US
18 Dec 2025 //
FDA
Teva To Host Conference Call On Q4 2025 Financial Results On Jan
12 Dec 2025 //
GLOBENEWSWIRE
Teva Releases Q4 2025 Aide Memoire
12 Dec 2025 //
GLOBENEWSWIRE
Enforcement Report - Week of December 10, 2025
10 Dec 2025 //
FDA
Teva Moves To Delist 200-Plus Patents From FDA Registry: FTC
10 Dec 2025 //
FIERCE PHARMA
Teva Submits FDA Application For Olanzapine Injectable
09 Dec 2025 //
GLOBENEWSWIRE
Teva’s Receives First Generic Approval for Estradio in US
08 Dec 2025 //
FDA
Teva Pharms’ Generics Estradiol Receives Approval in US
08 Dec 2025 //
FDA
How one company’s focus on the patient journey fuels innovation
08 Dec 2025 //
FIERCE PHARMA
Teva Gets EU Nod for Ponlimsi and Degevma Biosimilars
27 Nov 2025 //
PHARMIWEB
Teva Gets Eu Nod for Ponlimsi and Degevma Biosimilars
26 Nov 2025 //
PHARMIWEB
Teva Gets EU Nod for Ponlimsi & Degevma Biosimilars
26 Nov 2025 //
GLOBENEWSWIRE
Teva To Present At Multiple Healthcare Conferences In December
21 Nov 2025 //
GLOBENEWSWIRE
Teva Launches Rise to Speed for AI and Biotech Breakthroughs
19 Nov 2025 //
GLOBENEWSWIRE
Teva Debuts Innovation Platform To Parry Key Industry Challenges
19 Nov 2025 //
FIERCE PHARMA
Teva’ Generics Atorvastatin Calcium Receives Approval in US
13 Nov 2025 //
FDA
Enforcement Report - Week of November 12, 2025
12 Nov 2025 //
FDA
Fresenius, Sun, Teva & Others Launched Drug Recalls This Fall
12 Nov 2025 //
FIERCE PHARMA
Teva`s Austedo Shows Real-World Benefits In Tardive Dyskinesia
07 Nov 2025 //
GLOBENEWSWIRE
Teva Reports 11th Consecutive Quarter Of Growth
06 Nov 2025 //
INDPHARMAPOST
Teva`s Innovative Portfolio Drives Quarter of Growth in Q3 2025
05 Nov 2025 //
GLOBENEWSWIRE
Enforcement Report - Week of November 5, 2025
05 Nov 2025 //
FDA
Teva CEO Touts `Defining Strength` Of Innovative Drugs
05 Nov 2025 //
FIERCE PHARMA
Teva Drafts Terrell Davis For Tardive Dyskinesia Awareness Drive
05 Nov 2025 //
FIERCE PHARMA
Teva Kicks ‘Other TD’ to Raise Awareness of Tardive Dyskinesia
03 Nov 2025 //
GLOBENEWSWIRE
Teva To Present at UBS & Jefferies Healthcare Conferences
31 Oct 2025 //
GLOBENEWSWIRE
Teva Settles Asthma Inhaler Antitrust Lawsuit For $35M
27 Oct 2025 //
REUTERS
Teva’s Receives First Generic Approval for Dalbavancin in US
23 Oct 2025 //
FDA
Teva’s Generics Dalbavancin Hydrochloride Receives Approval in US
23 Oct 2025 //
FDA
Teva, Prestige Bio Sign Deal For Tuznue® Commercialization
20 Oct 2025 //
GLOBENEWSWIRE
FDA Approves UZEDY® For Bipolar I Disorder In Adults
10 Oct 2025 //
GLOBENEWSWIRE
FDA Approves Another Generic Version of Abortion Pill
03 Oct 2025 //
REUTERS
Teva Releases Q3 2025 Aide Memoire
25 Sep 2025 //
GLOBENEWSWIRE
Teva To Discuss Q3 2025 Financial Results In Conference Call
25 Sep 2025 //
GLOBENEWSWIRE
Teva And Medincell`s Risperidone Lai Receives Health Canada
23 Sep 2025 //
PHARMAWEB
Bausch, Teva Accused of Delaying Generic Xifaxan
23 Sep 2025 //
REUTERS
Teva Reveals Promising SOLARIS Results for Olanzapine LAI
23 Sep 2025 //
INDPHARMAPOST
Medincell, Teva to Host Investor Call on Phase 3 Olanzapine LAI
17 Sep 2025 //
PHARMAWEB
Teva to Release Ph 3 SOLARIS Olanzapine LAI Data Sep 22, 2025
16 Sep 2025 //
GLOBENEWSWIRE
Teva`s Generics Macitentan Receives Tentative Approval in US
15 Sep 2025 //
FDA
Corcept Faces Teva Lawsuit Over Mifepristone `Monopoly`
15 Sep 2025 //
REUTERS
FDA Fast Tracks Teva`s Emrusolmin
09 Sep 2025 //
GLOBENEWSWIRE
Colorado to Face Teva`s Lawsuit Over Allergy Pen Law
05 Sep 2025 //
REUTERS
Teva to Present at September Healthcare Conferences
02 Sep 2025 //
GLOBENEWSWIRE
Teva Brings 1st GLP-1 Generic for Obesity, Targets Novo’s Saxenda
30 Aug 2025 //
BIOSPACE
Teva’s Receives First Generic Approval for Liraglutide in US
27 Aug 2025 //
FDA
Teva’s Generics Liraglutide Receives Approval in US
27 Aug 2025 //
FDA
MedImpact offers low-cost ustekinumab-aekn biosimilar to US
18 Aug 2025 //
BUSINESSWIRE
Senores Acquires ANDAs from Teva Pharmaceuticals USA
14 Aug 2025 //
INDPHARMAPOST
FDA Approves Teva`s Ajovy for Migraine Prevention in Children
06 Aug 2025 //
REUTERS
Teva`s Biologics Ajovy Receives Suppl Approval in US
05 Aug 2025 //
FDA
Teva Execs Unfazed by New Pharmaceutical Tariffs
30 Jul 2025 //
FIERCE PHARMA
Teva`s Q2 2025 Growth Streak Continues; Ups 2025 Revenue Forecast
30 Jul 2025 //
GLOBENEWSWIRE
J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
09 Jul 2025 //
REUTERS
